Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD Patients

Inclusion criteria

• COPD patient already treated by NIV requiring therapy assessment in their routine care Follow-Up or
• COPD patient requiring de Novo NIV therapy according to routine care rules (NIV<12h)
• Patient requiring NIV therapy by S9 VPAP ST +/- oxygen therapy
• Patient willing to participate to the study
• Patient or attendant able to complete patient passport and to come to Follow-Up visits.

Exclusion criteria

• NIV therapy Failure during screening phase (intolerance, patient refusal, significant leaks, significant AHI or Oxymetry events)
• Hospitalization conducting to NIV discontinuation for at least 1 week during the screening phase